Gershon Y. Locker
- Oncology top 0.2%
- Cancer Research top 0.2%
- Molecular Biology top 5%
- Genetics top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Co-authors
- James H. DoroshowCharles E. MyersJack CuzickAnthony HowellRobert C. BastJ. Milburn JessupNancy E. KemenyMark R. Somerfield
- Topics
- PARP inhibition in cancer therapy (24 papers)Pancreatic and Hepatic Oncology Research (23 papers)Cancer Genomics and Diagnostics (16 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Gershon Y. Locker
75 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 6.1k
- Cancer Research 3.0k
- Molecular Biology 2.2k
- Genetics 2.1k
- Pulmonary and Respiratory Medicine 1.8k
Countries citing papers authored by Gershon Y. Locker
This map shows the geographic impact of Gershon Y. Locker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gershon Y. Locker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gershon Y. Locker more than expected).
Fields of papers citing papers by Gershon Y. Locker
This network shows the impact of papers produced by Gershon Y. Locker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gershon Y. Locker. The network helps show where Gershon Y. Locker may publish in the future.
Co-authorship network of co-authors of Gershon Y. Locker
This figure shows the co-authorship network connecting the top 25 collaborators of Gershon Y. Locker. A scholar is included among the top collaborators of Gershon Y. Locker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gershon Y. Locker. Gershon Y. Locker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 120 | |
| 3 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancerbreakdown → | 1468 |
| 4 | 9 | |
| 5 | 9 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 87 | |
| 9 | 47 | |
| 10 | 62 | |
| 11 | 201 | |
| 12 | 12 | |
| 13 | Regulation of Fatty Acid Synthase (FAS) gene expression by Peroxisome Proliferator-activated receptor-gamma (PPARγ) is dependent of Her-2/neu (erbB-2) signaling in breast cancer cells | 3 |
| 14 | 6 | |
| 15 | 27 | |
| 16 | 22 | |
| 17 | Breast surgery in the ATAC trial: women from the United States are more likely to have mastectomy. | 6 |
| 18 | 42 | |
| 19 | Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markersbreakdown → | 553 |
| 20 | 5 |
About Gershon Y. Locker
Gershon Y. Locker is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 76 papers that have together received 9.5k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (24 papers), Pancreatic and Hepatic Oncology Research (23 papers) and Cancer Genomics and Diagnostics (16 papers). The work is most often cited by research in Oncology (6.1k citations), Cancer Research (3.0k citations) and Genetics (2.1k citations). Gershon Y. Locker has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include James H. Doroshow, Charles E. Myers, Jack Cuzick, Anthony Howell, Robert C. Bast, J. Milburn Jessup, Nancy E. Kemeny, Mark R. Somerfield, Daniel F. Hayes and G Hoctin-Boes. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.